FDA Used ‘Critically Flawed’ Risk-Benefit Analysis to ‘Justify’ COVID Vaccines for Children
The U.S. FDA relied on a critically flawed risk-benefit assessment to authorize emergency use of Pfizer’s COVID-19 vaccine for children 5-11 years of age.
The U.S. FDA relied on a critically flawed risk-benefit assessment to authorize emergency use of Pfizer’s COVID-19 vaccine for children 5-11 years of age.
Both HCQ and Ivermectin have been in wide use for decades and are so safe that in most countries they are available as over-the-counter purchases …
By Children’s Health Defense Team. The numbers reflect the latest data available as of Feb. 4 from the CDC’s Vaccine Adverse Event Reporting System website. Of the 653 reported deaths, 602 were from the U.S….